Diversified Healthcare Trust

Fundamentals6.0
Price Action6.0
News Sentiment6.0
AI Rating
5.5

Key Drivers

  • Positive FCF
  • Improving EBITDA
  • High leverage

AI
AI Summary

5.5

DHC's investment case has shifted from an operations-led turnaround to a balance-sheet recovery where completing non‑core asset sales and converting one‑time proceeds into sustainable cash flow (AFFO) is the single biggest determinant of upside, so investors should treat future distributions and valuation recovery as contingent on clean execution of those disposals. Monitor (1) progress on remaining LOIs/closings and realized sale pricing, (2) capex normalization to preserve FCF, and (3) SHOP operator NOI improvements—misses on any of these would likely re‑introduce refinancing and leverage stress.

CapitalRecycle
ExecutionRisk
Leverage‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Positive FCF
  • Improving EBITDA
  • High leverage

DHC generates strong free cash flow and improving EBITDA despite a full-year accounting loss and weak returns, but elevated leverage and high capex materially constrain financial flexibility.

Recovery
Leverage

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Pullback below average
  • Support at $6.10
  • Resistance $7.55

Price shows a weakening short-term uptrend over the last month — recent pullback from early‑March highs (resistance ≈ $7.55) leaves the stock below the last-month average with key support at $6.10 (secondary band high-$6s); a break below $6.10 would be bearish while RSI (~39) leaves room for a bounce.

mixed
watchdown
Support Level: $6.10 (secondary: $6.80–$6.99)
Resistance Level: $7.55

Retraced from early‑March peak into 2026-03-20

Sentiment & News

6.0

Key News Insights:

  • Q4 FFO miss
  • Institutional stake
  • Healthcare REIT uptrend

DHC missed Q4 FFO and revenue, but a new Centersquare stake and a stronger healthcare-REIT backdrop focus attention on its 2026 guidance.

InvestorInterest
QuarterlyMiss

The miss pressures near-term sentiment, but the new institutional position and sector strength could stabilize shares as investors re-evaluate 2026 guidance